Global drug maker Pfizer and biotech firm Amgen, each valued at over HK$1 trillion (US$153 billion), are among 22 strategic enterprises planning to open or expand offices in Hong Kong, the South China Morning Post has learned.
A source said on Monday that these industry leaders were among companies from the fintech, cloud computing and aerial transport sectors set to sign agreements with the Office for Attracting Strategic Enterprises. The move will mark the sixth cohort under the government’s flagship investment-attraction initiative since its launch.
Pfizer is a leading global research-based pharmaceutical and biotechnology company. As of April, it has a market capitalisation of HK$1.2 trillion.
Amgen, meanwhile, is one of the world’s largest independent biotechnology companies. It was founded in 1980 and is headquartered in California.
The firm focuses on discovering, developing and delivering human therapeutics for serious illnesses, using advanced human genetics and molecular biology to treat diseases in oncology, cardiology, bone health, inflammation and nephrology.
As of April 2026, Amgen’s market capitalisation is approximately HK$1.5 trillion.
According to the insider, the sixth batch also includes German firm Boehringer Ingelheim, mainland China’s Jiangsu Hengrui Pharmaceuticals, and HAYA Therapeutics, which focuses on life and health technology.
In the transport sector, the government had secured commitments from Chinese ride-hailing giant DiDi and electric vertical take-off and landing (eVTOL) manufacturer AutoFlight, the source said.
Shanghai-based AutoFlight is a leading eVTOL firm, valued at more than 1 billion yuan (US$146.7 million).
Its “lift and cruise” technology combines helicopter-like vertical take-off with the efficiency of conventional flight. The aircraft can be used as a sports aircraft, an autonomous cargo drone, and an air taxi.
The fintech sector includes PalmPay, a leading financial technology company and neobank serving emerging markets in Africa and Asia, with more than 40 million registered users worldwide.
Among cloud computing-related firms setting up in the city is LightSpeed Studios, a global game development studio under Tencent Games, supported by Tencent Cloud’s technology stack for development, operations and global scalability.
Financial Secretary Paul Chan Mo-po said on Sunday that the new batch of enterprises would include life and health technology companies regarded as world leaders in their fields.
“They will conduct clinical research in Hong Kong, further bolstering the city’s position in international medical research and development,” Chan added.